National health insurer Centene is pulling out of Hawaii's Medicaid market, leaving 24,000 members in need of a new plan. For ...
Quest Diagnostics is investigating unauthorized access to its Quanum Lab Services Manager after certain patient records were ...
Australia's 2026 cyber threat report reveals a 20% rise in security incidents and an 80% surge in warnings as AI accelerates ...
Zacks Investment Research on MSN
Waters & Labcorp expand access to FDA-approved HPV screening tests
Waters WAT recently announced a partnership with Labcorp Holdings Inc. LH to expand access to the FDA-approved BD Onclarity ...
Zacks Investment Research on MSN
Why Quest Diagnostics (DGX) is a top value stock for the long term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
Quest Diagnostics (DGX) has an average rating of overweight and mean price target of $257.57, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from ...
Waters Corporation & Quest Diagnostics help close cervical cancer screening gap with FDA-cleared At-Home HPV screening option: Our Bureau, Bengaluru Tuesday, October 27, 2026, 09: ...
The collaboration will introduce the FDA-cleared Onclarity Self-Collection Kit across clinical, health plan and consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results